SENSITIVITY OF COMBINED CHEMO- AND ANTIANGIOGENIC THERAPY RESULTS IN DIFFERENT MODELS DESCRIBING CANCER GROWTH

被引:5
|
作者
Dolbniak, Marzena [1 ]
Kardynska, Malgorzata [1 ]
Smieja, Jaroslaw [1 ]
机构
[1] Silesian Tech Univ, Syst Engn Grp, Akad 16, PL-44100 Gliwice, Poland
来源
关键词
Chemotherapy; antiangiogenic therapy; sensitivity; ANTICANCER THERAPY; SYSTEMS BIOLOGY; TUMOR-GROWTH; ANGIOGENESIS; ROBUSTNESS;
D O I
10.3934/dcdsb.2018009
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
This paper is concerned with analysis of two anticancer therapy models focused on sensitivity of therapy outcome with respect to model structure and parameters. Realistic periodic therapies are considered, combining cytotoxic and antiangiogenic agents, defined on a fixed time horizon. Tumor size at the end of therapy and average tumor size calculated over therapy horizon are chosen to represent therapy outcome. Sensitivity analysis has been performed numerically, concentrating on model parameters and structure at one hand, and on treatment protocol parameters, on the other. The results show that sensitivity of the therapy outcome highly depends on the model structure, helping to discern a good model. Moreover, it is possible to use this analysis to find a good protocol in case of heterogeneous tumors.
引用
收藏
页码:145 / 160
页数:16
相关论文
共 50 条
  • [1] Polydopamine Nanoparticles for Combined Chemo- and Photothermal Cancer Therapy
    Zhu, Zhijun
    Su, Ming
    NANOMATERIALS, 2017, 7 (07)
  • [2] Multifunctional nanoparticle systems for combined chemo- and photothermal cancer therapy
    Wang, Hai
    Zhao, Yu-Liang
    Nie, Guang-Jun
    FRONTIERS OF MATERIALS SCIENCE, 2013, 7 (02) : 118 - 128
  • [3] Mesoporous Polydopamine Nanobowls Toward Combined Chemo- and Photothermal Cancer Therapy
    Acter, Shahinur
    Jahan, Nazneen
    Vidallon, Mark Louis P.
    Teo, Boon Mian
    Tabor, Rico F.
    PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION, 2022, 39 (07)
  • [4] The combined chemo- and Rontgen therapy of malign tumours
    Seeligmann, L
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1913, 39 : 1310 - 1312
  • [5] Calcium carbonate carriers for combined chemo- and radionuclide therapy of metastatic lung cancer
    Timin, Alexander S.
    Postovalova, Alisa S.
    Karpov, Timofey E.
    Antuganov, Dmitrii
    Bukreeva, Anastasia S.
    Akhmetova, Darya R.
    Rogova, Anna S.
    Muslimov, Albert R.
    Rodimova, Svetlana A.
    Kuznetsova, Daria S.
    Zyuzin, Mikhail, V
    JOURNAL OF CONTROLLED RELEASE, 2022, 344 : 1 - 11
  • [6] RESULTS OF COMBINED CHEMO- AND RADIOTHERAPY OF OSTEOSARCOMA PULMONARY METASTASES
    Abdurasulov, R.
    Gafur-Akhunov, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 416 - 416
  • [7] Calcium carbonate carriers for combined chemo- and radionuclide therapy of metastatic lung cancer
    Timin, Alexander S.
    Postovalova, Alisa S.
    Karpov, Timofey E.
    Antuganov, Dmitrii
    Bukreeva, Anastasia S.
    Akhmetova, Darya R.
    Rogova, Anna S.
    Muslimov, Albert R.
    Rodimova, Svetlana A.
    Kuznetsova, Daria S.
    Zyuzin, Mikhail V.
    Journal of Controlled Release, 2022, 344 : 1 - 11
  • [8] Dual-Targeting Biomimetic Nanomaterials for Photo-/Chemo-/Antiangiogenic Synergistic Therapy
    Zhang, Yuanying
    Yang, Nan
    Dong, Ziyi
    Wu, Jiahui
    Liao, Rui
    Zhang, Yanling
    Zhang, Gege
    Ren, Mengfei
    Wang, Feng
    Dong, Xiaochen
    Liang, Pingping
    ACS APPLIED MATERIALS & INTERFACES, 2023, 15 (28) : 33288 - 33298
  • [9] Nanoparticles for Triple Drug Release for Combined Chemo- and Photodynamic Therapy
    Martinez-Edo, Gabriel
    Xue, Evelyn Y.
    Ha, Summer Y. Y.
    Ponton, Iris
    Antonio Gonzalez-Delgado, Jose
    Borros, Salvador
    Torres, Tomas
    Ng, Dennis K. P.
    Sanchez-Garcia, David
    CHEMISTRY-A EUROPEAN JOURNAL, 2021, 27 (59) : 14610 - 14618
  • [10] Hybrid Lipid Polymer Nanoparticles for Combined Chemo- and Photodynamic Therapy
    N'Diaye, Marline
    Vergnaud-Gauduchon, Juliette
    Nicolas, Valerie
    Faure, Victor
    Denis, Stephanie
    Abreu, Sonia
    Chaminade, Pierre
    Rosilio, Veronique
    MOLECULAR PHARMACEUTICS, 2019, 16 (09) : 4045 - 4058